[go: up one dir, main page]

NO20075541L - Mono-lysine salter av azolforbindelser - Google Patents

Mono-lysine salter av azolforbindelser

Info

Publication number
NO20075541L
NO20075541L NO20075541A NO20075541A NO20075541L NO 20075541 L NO20075541 L NO 20075541L NO 20075541 A NO20075541 A NO 20075541A NO 20075541 A NO20075541 A NO 20075541A NO 20075541 L NO20075541 L NO 20075541L
Authority
NO
Norway
Prior art keywords
mono
compounds
fungal
formula
triazole
Prior art date
Application number
NO20075541A
Other languages
English (en)
Norwegian (no)
Inventor
Chung-Pin Chen
Michael G Fakes
Yadagiri Pendri
Qi Gao
Susanne Kiau
Blisse Vakkalagadda
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of NO20075541L publication Critical patent/NO20075541L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20075541A 2005-05-03 2007-11-02 Mono-lysine salter av azolforbindelser NO20075541L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67693205P 2005-05-03 2005-05-03
PCT/JP2006/309435 WO2006118351A1 (fr) 2005-05-03 2006-05-01 Sels mono-lysines de composes azoles

Publications (1)

Publication Number Publication Date
NO20075541L true NO20075541L (no) 2007-11-28

Family

ID=36910951

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075541A NO20075541L (no) 2005-05-03 2007-11-02 Mono-lysine salter av azolforbindelser

Country Status (33)

Country Link
US (1) US20060264406A1 (fr)
EP (1) EP1877403B1 (fr)
JP (1) JP4015691B1 (fr)
KR (1) KR100887044B1 (fr)
CN (1) CN101213193B (fr)
AR (1) AR053862A1 (fr)
AT (1) ATE503753T1 (fr)
AU (1) AU2006241694B2 (fr)
BR (1) BRPI0610423B8 (fr)
CA (1) CA2606185C (fr)
CY (1) CY1111569T1 (fr)
DE (1) DE602006020998D1 (fr)
DK (1) DK1877403T3 (fr)
EC (1) ECSP077812A (fr)
ES (1) ES2361768T3 (fr)
HR (1) HRP20110467T1 (fr)
IL (1) IL187059A (fr)
JO (1) JO2691B1 (fr)
MX (1) MX2007013605A (fr)
MY (1) MY138095A (fr)
NO (1) NO20075541L (fr)
NZ (1) NZ563092A (fr)
PE (1) PE20071423A1 (fr)
PL (1) PL1877403T3 (fr)
PT (1) PT1877403E (fr)
RS (1) RS51779B (fr)
RU (1) RU2399625C2 (fr)
SA (1) SA06270126B1 (fr)
SI (1) SI1877403T1 (fr)
TW (1) TWI363630B (fr)
UY (1) UY29507A1 (fr)
WO (1) WO2006118351A1 (fr)
ZA (1) ZA200709127B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1964843B1 (fr) 2005-12-20 2013-08-28 Eisai R&D Management Co., Ltd. Procede pour produire un promedicament d'azole hydrosoluble
WO2007097386A1 (fr) 2006-02-22 2007-08-30 Eisai R & D Management Co., Ltd. Composition pharmaceutique stabilisee
CN105287403A (zh) * 2014-08-02 2016-02-03 陕西合成药业股份有限公司 一种泊沙康唑前体药物的冻干组合物及其制备方法和用途
CN106432338A (zh) * 2015-08-08 2017-02-22 陕西合成药业股份有限公司 泊沙康唑衍生物、合成和在长效制剂中的用途
WO2019106571A1 (fr) 2017-11-28 2019-06-06 Roivant Sciences Gmbh Schémas posologiques pour le traitement d'infections fongiques
CN110938093B (zh) * 2018-09-21 2022-08-19 华创合成制药股份有限公司 一种泊沙康唑磷酸酯单胆碱盐及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU681753B2 (en) * 1993-12-21 1997-09-04 Merck Sharp & Dohme Corp. Tetrahydrofuran antifungals
PT741737E (pt) * 1994-01-24 2000-04-28 Janssen Pharmaceutica Nv Antifungicos do tipo azole soluveis em agua
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
US5883097A (en) * 1998-04-16 1999-03-16 Schering Corporation Soluble azole antifungal salt
US6265584B1 (en) * 1998-05-22 2001-07-24 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
WO2000030655A1 (fr) * 1998-11-20 2000-06-02 Bristol-Myers Squibb Company Promedicaments solubles a l'eau comprenant des composes de type azole
US6235728B1 (en) * 1999-02-19 2001-05-22 Bristol-Myers Squibb Company Water-soluble prodrugs of azole compounds
US6362172B2 (en) * 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
US6448401B1 (en) * 2000-11-20 2002-09-10 Bristol-Myers Squibb Company Process for water soluble azole compounds

Also Published As

Publication number Publication date
SI1877403T1 (sl) 2011-05-31
PL1877403T3 (pl) 2011-08-31
EP1877403A1 (fr) 2008-01-16
HK1117502A1 (en) 2009-01-16
JO2691B1 (en) 2013-03-03
NZ563092A (en) 2010-06-25
DE602006020998D1 (de) 2011-05-12
HRP20110467T1 (hr) 2011-07-31
RU2007140788A (ru) 2009-06-10
BRPI0610423B1 (pt) 2020-11-10
CA2606185C (fr) 2012-08-28
AU2006241694A1 (en) 2006-11-09
RU2399625C2 (ru) 2010-09-20
TWI363630B (en) 2012-05-11
IL187059A (en) 2012-08-30
JP2008544948A (ja) 2008-12-11
UY29507A1 (es) 2006-11-30
CN101213193B (zh) 2011-02-02
CN101213193A (zh) 2008-07-02
WO2006118351A1 (fr) 2006-11-09
PT1877403E (pt) 2011-05-31
MX2007013605A (es) 2008-01-24
EP1877403B1 (fr) 2011-03-30
PE20071423A1 (es) 2006-12-17
ATE503753T1 (de) 2011-04-15
CA2606185A1 (fr) 2006-11-09
RS51779B (sr) 2011-12-31
MY138095A (en) 2009-04-30
US20060264406A1 (en) 2006-11-23
KR100887044B1 (ko) 2009-03-04
ECSP077812A (es) 2008-01-23
ZA200709127B (en) 2008-07-30
BRPI0610423B8 (pt) 2021-05-25
CY1111569T1 (el) 2015-10-07
JP4015691B1 (ja) 2007-11-28
IL187059A0 (en) 2008-02-09
ES2361768T3 (es) 2011-06-22
BRPI0610423A2 (pt) 2010-06-22
AR053862A1 (es) 2007-05-23
DK1877403T3 (da) 2011-05-09
KR20070088460A (ko) 2007-08-29
SA06270126B1 (ar) 2009-09-02
TW200722093A (en) 2007-06-16
AU2006241694B2 (en) 2011-10-20

Similar Documents

Publication Publication Date Title
NO20075541L (no) Mono-lysine salter av azolforbindelser
NO20084179L (no) Fremgangsmate for produksjon av 4-oksokinolinforbindelser
CY1120559T1 (el) Παραγωγα 1-(ακετυλ)-πιπεριδινης και 1-(ακετυλ)-πιπεραζινης ως μυκητοκτονα για χρηση στη φυτοπροστασια
CY1119569T1 (el) Μυκητοκτονες ενωσεις και μειγματα
TN2009000024A1 (en) Prodrug of cinnamide compound
NO20082630L (no) Vann-opploslige benzoazepinforbindelser og farmasoytisk forbindelse
DE602006019788D1 (de) Oximester-Fotoinitiatoren
JP2015504112A5 (fr)
NZ601567A (en) Process for production of delta-9-tetrahydrocannabinol
NO20081930L (no) Oksazolforbindelser og farmasoytiske blandinger
NO20073956L (no) Pyrazolderivater for inhibering av CDK og GSK
NO20082338L (no) Pyrimidinderivater for behandling av avvikende cellevekst
NO20065578L (no) Substituerte metylaryl eller heteroarylamidforbindelser
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
NO20064003L (no) Nyekarboksamider for anvendelse som XA-inhibitorer
WO2009041095A1 (fr) Colorant capillaire et composition de teinture capillaire
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
WO2008078305A3 (fr) Dérivés de 4-(1-amino-éthyl)-cyclohexylamine
GB2470170A (en) Dithienothiophene derivatives
MY169869A (en) Pyrrolidine-3-ylacetic acid derivative
BRPI0502897A (pt) compostos corantes
NO20076020L (no) 1,2-di(cyklisk gruppe)sibstituert benzenderivat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application